Dosimetric techniques in 90Y-microsphere therapy of liver cancer: The MIRD equations for dose calculations

Journal of Nuclear Medicine

Volumn 47, Issue 7, 2006, Pages 1209-1211

  Gulec, Seza A ^a   Mesoloras, Geraldine ^a   Stabin, Michael ^b  

^a Goshen Health System Center for Cancer Care   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSPHERE Y 90; RADIOACTIVE MICROSPHERE; RESIN; UNCLASSIFIED DRUG; MICROSPHERE; YTTRIUM;

BIOCOMPATIBILITY; CLINICAL PRACTICE; DOSIMETRY; DRUG HALF LIFE; FRACTIONATION; HEPATIC ARTERY; HUMAN; LIVER CANCER; LIVER PARENCHYMA; MEDICAL LITERATURE; MICROVASCULATURE; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; SHORT SURVEY; STATISTICAL ANALYSIS; ARTICLE; LIVER TUMOR; METHODOLOGY; PATHOLOGY; RADIOMETRY; TREATMENT OUTCOME;

DATA INTERPRETATION, STATISTICAL; HEPATIC ARTERY; HUMANS; LIVER NEOPLASMS; MICROSPHERES; RADIOMETRY; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 33747103178     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (12)

1. Murthy R, Xiong H, Nunez R, et al. Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol. 2005;16:937-945.
2. Lau WY, Ho SK, Yu SC, Lai EC, Liew CT, Leung TW. Salvage surgery following downstaging of unresectable hepatocellular carcinoma. Ann Surg. 2004;240:299-305.
3. Ariel IM, Padula G. Treatment of symptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intra-arterial administration of chemotherapy and radioactive isotopes. J Surg Oncol. 1978;10:327-336.
4. Ariel IM, Padula G. Treatment of asymptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intra-arterial administration of chemotherapy and radioactive isotopes. J Surg Oncol. 1982;20:151-156.
5. Van Hazel G, Blackwell A, Anderson J, et al. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol. 2004;88:78-85.
6. Gray B, Van Hazel G, Hope M, et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol. 2001;12:1711-1720.
7. Lau WY, Leung WT, Ho S, et al. Treatment of inoperable hepatocellular carcinoma with intrahepatic yttrium-90 microspheres: a phase I and II study. Br J Cancer. 1994;70:994-999.
8. Rubin D, Nutting C, Jones B. Metastatic breast cancer in a 54-year-old woman: integrative treatment with yttrium-90 radioembolization. Integr Cancer Ther. 2004;3:262-267.
9. King J, Morris D, Glenn D, et al. SIR-Spheres for liver metastases from neuroendocrine tumors. In: Abstracts of the 2005 WCGIC (9th World Congress on Gastrointestinal Cancer); Barcelona, Spain. Abstract P-090.
10. Liu D, Salem R, Bui J, et al. Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol. 2005;16:911-935.
11. Siegel JA, Handy DM, Kopher KA, et al. Therapeutic beta irradiating isotopes in bony metastasis: a technique for bremsstrahlung imaging and quantitation. Antibody Immunoconjugates Radiopharm. 1992;5:237-248.
12. Siegel JA, Zeiger LS, Order SE, Wallner PE. Quantitative bremsstrahlung single photon emission computed tomographic imaging: use for volume, activity, and absorbed dose calculations. Int J Radiat Oncol Biol Phys. 1995;31:953-958.